Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)
Clinical trial NCT06158334 · UNKNOWN
Trial details
- NCT number
- NCT06158334
- Sponsor
- Hospices Civils de Lyon
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-06-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.